RightFit Trial Directory

Breast Cancer clinical trials in Philadelphia, PA

25 recruiting breast cancer studies with a site in Philadelphia, PA.

All trials in Philadelphia, PA · All Breast Cancer trials

RecruitingPhase 3NCT07391774

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI)

Hershey, PA · Philadelphia, PA · +200 more sites

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Bethlehem, PA · Lancaster, PA · Philadelphia, PA · +126 more sites

RecruitingPhase 1 / Phase 2NCT05898399

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

Sponsor: Artios Pharma Ltd

Philadelphia, PA · +6 more sites

RecruitingPhase 3NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Sponsor: Stemline Therapeutics, Inc.

Allen, PA · Broomall, PA · Hershey, PA · +173 more sites

RecruitingPhase not listedNCT05059444

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Sponsor: Guardant Health, Inc.

Broomall, PA · Philadelphia, PA · York, PA · +30 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Allentown, PA · Bethlehem, PA · +1223 more sites

RecruitingPhase 1NCT07216105

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Sponsor: Fate Therapeutics

Philadelphia, PA · +4 more sites

RecruitingPhase not listedNCT06888388

Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Philadelphia, PA · +4 more sites

RecruitingPhase 1NCT07182149

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Sponsor: Normunity AccelCo, Inc.

Philadelphia, PA · +16 more sites

RecruitingNot applicableNCT07737951

Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia

Sponsor: Thomas Jefferson University

Philadelphia, PA

RecruitingPhase 3NCT05232916

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Sponsor: Greenwich LifeSciences, Inc.

Meadowbrook, PA · Philadelphia, PA · +49 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Allentown, PA · Bethlehem, PA · Chambersburg, PA · +825 more sites

RecruitingPhase 1NCT06545942

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Sponsor: MOMA Therapeutics

Philadelphia, PA · +11 more sites

RecruitingPhase not listedNCT06551116

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Sponsor: Abramson Cancer Center at Penn Medicine

Philadelphia, PA · Pittsburgh, PA · +34 more sites

RecruitingEarly Phase 1NCT07319195

Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)

Sponsor: Jennifer Zhang

Philadelphia, PA

RecruitingPhase 2NCT04434040

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

Sponsor: Dana-Farber Cancer Institute

Philadelphia, PA · +6 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Allentown, PA · Bethlehem, PA · Broomall, PA · +809 more sites

RecruitingPhase not listedNCT03448926

The PREDICT Registry:

Sponsor: PreludeDx

Easton, PA · Philadelphia, PA · Pittsburgh, PA · +27 more sites

RecruitingPhase 1 / Phase 2NCT06395519

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Sponsor: 858 Therapeutics, Inc.

Philadelphia, PA · +13 more sites

RecruitingPhase not listedNCT06694181

Safe and Explainable AI

Sponsor: Abramson Cancer Center at Penn Medicine

Philadelphia, PA

RecruitingPhase 3NCT06435429

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

Sponsor: Jazz Pharmaceuticals

Philadelphia, PA · +46 more sites

RecruitingNot applicableNCT04959474

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Sponsor: Thomas Jefferson University

Philadelphia, PA

RecruitingPhase 4NCT04373564

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Sponsor: Guerbet

Hershey, PA · Philadelphia, PA · +14 more sites

RecruitingPhase not listedNCT04074720

Prospective Breast Cancer Biospecimen Collection

Sponsor: Thomas Jefferson University

Philadelphia, PA

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Allentown, PA · Bethlehem, PA · Bryn Mawr, PA · +952 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.